SAS chosen by SynbiCITE and Imperial College London to help drive new synthetic biology industry
Synthetic Biology Foundries; Factories of the Future
SAS, the leader in analytics, has been chosen by SynbiCITE and the Centre for Synthetic Biology & Innovation at Imperial College London to produce a Data Knowledge Centre for the storage, processing, analysis and predictive modelling of the data generated at the new London DNA Foundry.
This results of the project programme will help to transform leading edge academic research into commercial outputs for the emerging synthetic biology industry.
Synthetic Biology is expected to develop into a multi-billion pound industry and uses engineering principles to design and construct new biological parts, devices and systems. These can help tackle major global concerns around sustainability including environmental health, energy shortages, pollution, hunger and disease. In 2013 it was named by the UK Government as one of the eight great technologies in which the UK is set to be a global leader.
Imperial College London is a leading science-based institution and host to SynbiCITE, the Innovation and Knowledge Centre (IKC) for Synthetic Biology and funded by the UK government to drive commercialisation of synthetic biology and effectively create an industry from scratch. It focuses on using biology to create substitutes for a wide range of items, such as malaria medicines, rubber substitutes for tyres and crop feeds.
"This is an exciting and hugely important new field which has attracted support from the UK Government as well as a number of international bodies. The global synthetic biology market is estimated to reach $38.7 billion by 2020 and can have a significant impact on the economy, growth and jobs over the coming years," said Dr Steve Chambers, CEO of SynbiCITE.
"SAS was chosen on the basis of its leading reputation in health and life sciences, and to drive robustness and repeatability in translating academic research into industry-class outputs. These outputs will help development of new technology opportunities that can be exploited by new and existing businesses across many fields."
"SAS typically supports mature companies with mature business problems," said Mark Wilkinson, Regional Vice President – Northern Europe, SAS. "This deal is significant as we are supporting an early-stage organisation that is looking to grow an entirely new and ground-breaking industry. We are fortunate to be the start of something that is intended to be a multi-billion pound industry, and one which can address major concerns about global sustainability when it comes to use of increasingly scarce natural resources."
SynbiCITE is a pioneering Innovation and Knowledge Centre (IKC) dedicated to promoting the adoption and use of synthetic biology by industry. The IKC is an internationally recognised lead centre in industrialising synthetic biology research giving the UK a globally renowned national resource of interacting partners from across the UK’s leading academic institutions, industry and business.
SynbiCITE is focused at Imperial College London and is, with our partners, accelerating the commercialisation of world-class science and the emerging technologies encompassed by synthetic biology into new products, tools, processes and services. Our overall aim is to grow UK industry in the sector and improve synthetic biology, using industry to achieve significant economic impact, generate wealth for the companies, generate skilled workers and create jobs.
SAS helps 80,000 organisations around the world take their data… And do amazing things… We help organisations turn large amounts of data into knowledge they can use, and we do it better than anyone. It’s no wonder an overwhelming majority of customers continue to use SAS year after year. Find out more, Why SAS?